[PDF][PDF] Immunoinformatic investigation of three structural protein genes in Indonesian SARS-CoV-2 isolates
ANM Ansori, MKJ Kusala, I Normalina, S Indrasari… - Sys Rev …, 2020 - academia.edu
ABSTRACT Introduction: SARS-CoV-2 has crossed the species barrier to infect human. It is
a rapidly spreading virus that has poses a significant public threat and is a considerable …
a rapidly spreading virus that has poses a significant public threat and is a considerable …
[PDF][PDF] Characterization of the spike glycoprotein and construction of an epitope-based vaccine candidate against Indonesian SARS-CoV-2: In silico study
I Normalina, S Indrasari, RV Nidom, MKJ Kusala… - Sys Rev …, 2020 - academia.edu
ABSTRACT Introduction: SARS-CoV-2, a new member of the coronavirus family that
originated from Wuhan, China, is the agent of COVID-19 pandemic and has rapidly spread …
originated from Wuhan, China, is the agent of COVID-19 pandemic and has rapidly spread …
Immunobioinformatics analysis and phylogenetic tree construction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Indonesia: spike glycoprotein …
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which
causes coronavirus disease 2019 (COVID-19), has spread worldwide and as a result, the …
causes coronavirus disease 2019 (COVID-19), has spread worldwide and as a result, the …
[PDF][PDF] Viroinformatics investigation of B-cell epitope conserved region in SARS-CoV-2 lineage B. 1.1. 7 isolates originated from Indonesia to develop vaccine …
Abstract Resumen Context: SARS-CoV-2, a member of family Coronaviridae and the
causative agent of COVID-19, is a virus which is transmitted to human and other mammals …
causative agent of COVID-19, is a virus which is transmitted to human and other mammals …
[PDF][PDF] Potential Vaccine Targets for COVID-19 and Phylogenetic Analysis Based on the Nucleocapsid Phosphoprotein of Indonesian SARS-CoV-2 Isolates.
MA Hafidzhah, RM Wijaya, RT Probojati… - Indonesian Journal of …, 2021 - researchgate.net
Recently, the world is facing outbreaks of severe acute respiratory syndrome coronavirus 2
or SARS-CoV-2 and the number of infected patients is increasing every day. Researchers …
or SARS-CoV-2 and the number of infected patients is increasing every day. Researchers …
Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope‐Based Peptide Vaccine and Novel Compounds against Novel SARS‐CoV‐2 …
Background. Coronaviruses (CoVs) are enveloped positive‐strand RNA viruses which have
club‐like spikes at the surface with a unique replication process. Coronaviruses are …
club‐like spikes at the surface with a unique replication process. Coronaviruses are …
[HTML][HTML] Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics …
N Khairkhah, MR Aghasadeghi, A Namvar… - Plos one, 2020 - journals.plos.org
The causative agent of severe acute respiratory syndrome (SARS) reported by the Chinese
Center for Disease Control (China CDC) has been identified as a novel Betacoronavirus …
Center for Disease Control (China CDC) has been identified as a novel Betacoronavirus …
[HTML][HTML] Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches
Despite the availability of COVID-19 vaccines, additional more potent vaccines are still
required against the emerging variations of the severe acute respiratory syndrome …
required against the emerging variations of the severe acute respiratory syndrome …
In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct
A Sharma, S Pal, A Panwar, S Kumar, A Kumar - Immunobiology, 2021 - Elsevier
Abstract COVID-19 (CoronaVirus disease 2019) is caused by the SARS-CoV-2 virus (severe
acute respiratory syndrome corona virus 2). SARS-CoV-2 virus is highly contagious and …
acute respiratory syndrome corona virus 2). SARS-CoV-2 virus is highly contagious and …
Design an efficient multi-epitope peptide vaccine candidate against SARS-CoV-2: an in silico analysis
Z Yazdani, A Rafiei, M Yazdani… - Infection and drug …, 2020 - Taylor & Francis
Background To date, no specific vaccine or drug has been proven to be effective against
SARS-CoV-2 infection. Therefore, we implemented an immunoinformatic approach to …
SARS-CoV-2 infection. Therefore, we implemented an immunoinformatic approach to …
相关搜索
- sars cov vaccine candidate
- sars cov protein genes
- sars cov immunoinformatic approaches
- sars cov nucleocapsid phosphoprotein
- sars cov tree construction
- sars cov phylogenetic analysis
- sars cov omicron variant
- sars cov virtual screening
- sars cov spike glycoprotein
- sars cov covid 19
- sars cov glycoprotein gene
- sars cov peptide vaccine
- sars cov vaccine targets
- sars cov vaccine design
- sars cov silico analysis
- sars cov bioinformatics analysis